Endothelial progenitor cells: A new player in lupus?

Arthritis Research and Therapy

Volumn 14, Issue 1, 2012, Pages

  Haque, Sahena ^a,b   Alexander, M Yvonne ^c   Bruce, Ian N ^a,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b EAST LANCASHIRE HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; ENDOTHELIAL PROGENITOR CELL; HUMAN; PATHOGENESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; CELL COUNT; CULTURE TECHNIQUE; ENDOTHELIUM CELL; FLOW CYTOMETRY; PATHOLOGY; PATHOPHYSIOLOGY; STEM CELL; VASCULAR ENDOTHELIUM;

CELL COUNT; CELL CULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; STEM CELLS;

EID: 84857368358     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3700     Document Type: Review

References (63)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976, 60:221-225. 10.1016/0002-9343(76)90431-9, 1251849.
2. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, D'Agostino RB, Kuller LH. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997, 145:408-415.
3. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999, 42:338-346. 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U, 10025929.
4. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001, 44:2331-2337. 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I, 11665973.
5. El-Magadmi M, Bodill H, Ahmad Y, Durrington PN, Mackness M, Walker M, Bernstein RM, Bruce IN. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004, 110:399-404. 10.1161/01.CIR.0000136807.78534.50, 15262847.
6. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695. 10.1056/NEJMra043430, 15843671.
7. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007. 10.1056/NEJMoa043814, 16148285.
8. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005, 105:2783-2786. 10.1182/blood-2004-08-3057, 15585655.
9. Holmén C, Elsheikh E, Stenvinkel P, Qureshi AR, Pettersson E, Jalkanen S, Sumitran-Holgersson S. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol 2005, 16:3110-3120. 10.1681/ASN.2005040347, 16107582.
10. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967. 10.1126/science.275.5302.964, 9020076.
11. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999, 18:3964-3972. 10.1093/emboj/18.14.3964, 1171472, 10406801.
12. Khan SS, Solomon MA, McCoy JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005, 64:1-8.
13. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined?. J Cell Mol Med 2009, 13:87-102.
14. Cheng J, Baumhueter S, Cacalano G, Carver-Moore K, Thibodeaux H, Thomas R, Broxmeyer HE, Cooper S, Hague N, Moore M, Lasky LA. Hematopoietic defects in mice lacking the sialomucin CD34. Blood 1996, 87:479-490.
15. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90:5002-5012.
16. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
17. Roskoski R. VEGF receptor protein-tyrosine kinases: structure and regulation. Biochem Biophys Res Commun 2008, 375:287-291. 10.1016/j.bbrc.2008.07.121, 18680722.
18. Woodfin A, Voisin MB, Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 2007, 27:2514-2523. 10.1161/ATVBAHA.107.151456, 17872453.
19. Denis CV. Molecular and cellular biology of von Willebrand factor. Int J Hematol 2002, 75:3-8. 10.1007/BF02981972, 11843287.
20. Watt SM, Gschmeissner SE, Bates PA. PECAM-1: its expression and function as a cell adhesion molecule on hemopoietic and endothelial cells. Leuk Lymphoma 1995, 17:229-244. 10.3109/10428199509056827, 8580791.
21. Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML, Adamkiewicz J, Elsässer HP, Müller R, Havemann K. Endotheliallike cells derived from human CD14 positive monocytes. Diff erentiation 2000, 65:287-300.
22. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F, Cosmi L, Maggi L, Lasagni L, Scheffold A, Kruger M, Dimmeler S, Marra F, Gensini G, Maggi E, Romagnani S. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005, 97:314-322. 10.1161/01.RES.0000177670.72216.9b, 16020753.
23. Abu El-Asrar AM, Struyf S, Verbeke H, Van Damme J, Geboes K. Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes. Acta Ophthalmol 2011, 89:222-228. 10.1111/j.1755-3768.2009.01700.x, 19764917.
24. Pelliccia F, Pasceri V, Cianfrocca C, Vitale C, Pristipino C, Speciale G, Mercuro G, Rosano G. Endothelial progenitor cells in patients with coronary artery disease and left ventricular dysfunction. Coron Artery Dis 2009, 20:303-308. 10.1097/MCA.0b013e328325765e, 19528795.
25. Hu T, She Q, Jiang Y, Su L, Yin Y. Level of CD14+-endothelial progenitor cells is not associated with coronary artery disease or cardiovascular risk factors. Age (Dordr) 2008, 30:319-326. 10.1007/s11357-008-9074-z, 19424856.
26. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600. 10.1056/NEJMoa022287, 12584367.
27. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000, 105:71-77. 10.1172/JCI8071, 382587, 10619863.
28. Prokopi M, Mayr M. Proteomics: a reality-check for putative stem cells. Circ Res 2011, 108:499-511. 10.1161/CIRCRESAHA.110.226902, 21335432.
29. Jialal I, Fadini GP, Pollock K, Devaraj S. Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome. Am J Cardiol 2010, 106:1606-1608. 10.1016/j.amjcard.2010.07.039, 3052293, 21040691.
30. Jodon de Villeroché V, Avouac J, Ponceau A, Ruiz B, Kahan A, Boileau C, Uzan G, Allanore Y. Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity. Arthritis Res Ther 2010, 12:R27. 10.1186/ar2934, 2875661, 20158894.
31. Urbich C, De Souza AI, Rossig L, Yin X, Xing Q, Prokopi M, Drozdov I, Steiner M, Breuss J, Xu Q, Dimmeler S, Mayr M. Proteomic characterization of human early pro-angiogenic cells. J Mol Cell Cardiol 2011, 50:333-336. 10.1016/j.yjmcc.2010.11.022, 21147123.
32. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005, 106:1525-1531. 10.1182/blood-2005-04-1509, 15905185.
33. Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, Guelly C, Strunk D. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells 2007, 25:1746-1752. 10.1634/stemcells.2006-0833, 17395771.
34. Desai A, Glaser A, Liu D, Raghavachari N, Blum A, Zalos G, Lippincott M, McCoy JP, Munson PJ, Solomon MA, Danner RL, Cannon RO 3. Microarraybased characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Arterioscler Thromb Vasc Biol 2009, 29:121-127. 10.1161/ATVBAHA.108.174573, 2664554, 19092138.
35. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169. 10.1161/01.CIR.0000058702.69484.A0, 12615796.
36. Burt RK, Testori A, Oyama Y, Rodriguez HE, Yaung K, Villa M, Bucha JM, Milanetti F, Sheehan J, Rajamannan N, Pearce WH. Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant 2010, 45:111-116. 10.1038/bmt.2009.102, 19448678.
37. Kawamura A, Horie T, Tsuda I, Abe Y, Yamada M, Egawa H, Iida J, Sakata H, Onodera K, Tamaki T, Furui H, Kukita K, Meguro J, Yonekawa M, Tanaka S. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs 2006, 9:226-233. 10.1007/s10047-006-0351-2, 17171401.
38. Hernández P, Cortina L, Artaza H, Pol N, Lam RM, Dorticós E, Macias C, Hernández C, del Valle L, Blanco A, Martinez A, Diáz F. Autologous bonemarrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation. Atherosclerosis 2007, 194:e52-e56. 10.1016/j.atherosclerosis.2006.08.025, 16982058.
39. Assmus B, Rolf A, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Tillmanns H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Tonn T, Dimmeler S, Dill T, Zeiher AM, Schächinger V, . REPAIR-AMI Investigators Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010, 3:89-96. 10.1161/CIRCHEARTFAILURE.108.843243, 19996415, REPAIR-AMI Investigators.
40. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, Van Haute I, Lootens N, Heyndrickx G, Wijns W. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005, 112(9 Suppl):I178-I183.
41. Kirton JP, Xu Q. Endothelial precursors in vascular repair. Microvasc Res 2010, 79:193-199. 10.1016/j.mvr.2010.02.009, 20184904.
42. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, Inden Y, Murohara T. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004, 24:1442-1447. 10.1161/01.ATV.0000135655.52088.c5, 15191940.
43. Lenk K, Uhlemann M, Schuler G, Adams V. Role of endothelial progenitor cells in the beneficial effects of physical activity on atherosclerosis and coronary artery disease. J Appl Physiol 2011, 111:321-328.
44. Reinhard H, Jacobsen PK, Lajer M, Pedersen N, Billestrup N, Mandrup-Poulsen T, Parving HH, Rossing P. Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes. Diabetologia 2010, 53:2129-2133. 10.1007/s00125-010-1843-4, 20607514.
45. Muller P, Kazakov A, Jagoda P, Semenov A, Bohm M, Laufs U. ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload. Cardiovasc Res 2009, 83:106-114. 10.1093/cvr/cvp123, 19380417.
46. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S. Vascular trauma induces rapid but transient mobilization of VEGFR2+AC133+ endothelial precursor cells. Circ Res 2001, 88:167-174.
47. Yip HK, Tsai TH, Lin HS, Chen SF, Sun CK, Leu S, Yuen CM, Tan TY, Lan MY, Liou CW, Lu CH, Chang WN. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Crit Care 2011, 15:R40. 10.1186/cc10002, 3221969, 21269484.
48. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7. 10.1161/hh1301.093953, 11440984.
49. Westerweel PE, Luijten RK, Hoefer IE, Koomans HA, Derksen RH, Verhaar MC. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus. Ann Rheum Dis 2007, 66:865-870. 10.1136/ard.2006.065631, 1955125, 17329307.
50. Denny MF, Thacker S, Mehta H, Somers EC, Dodick T, Barrat FJ, McCune WJ, Kaplan MJ. Interferon-{alpha} promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007, 110:2907-2915. 10.1182/blood-2007-05-089086, 2018671, 17638846.
51. Moonen JR, de Leeuw K, van Seijen XJ, Kallenberg CG, van Luyn MJ, Bijl M, Harmsen MC. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2007, 9:R84. 10.1186/ar2283, 2206388, 17764548.
52. Baker JF, Zhang L, Imadojemu S, Sharpe A, Patil S, Moore JS, Mohler ER 3, Von Feldt J. Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification. Rheumatol Int 2011,
53. Deng XL, Li XX, Liu XY, Sun L, Liu R. Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage. Rheumatol Int 2010, 30:1429-1436. 10.1007/s00296-009-1156-4, 19847436.
54. Grisar J, Steiner CW, Bonelli M, Karonitsch T, Schwarzinger I, Weigel G, Steiner G, Smolen JS. Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells. Rheumatology 2008, 47:1476-1483. 10.1093/rheumatology/ken286, 18660509.
55. Ablin JN, Boguslavski V, Aloush V, Elkayam O, Paran D, Levartovski D, Caspi D, George J. Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE. Rheumatol Int 2011, 31:773-778. 10.1007/s00296-010-1377-6, 20213291.
56. Lee PY, Li Y, Richards HB, Chan FS, Zhuang H, Narain S, Butfiloski EJ, Sobel ES, Reeves WH, Segal MS. Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum 2007, 56:3759-3769. 10.1002/art.23035, 17968925.
57. Ebner P, Picard F, Richter J, Darrelmann E, Schneider M, Strauer BE, Brehm M. Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE. Rheumatology (Oxford) 2010, 49:63-72. 10.1093/rheumatology/kep335, 19995856.
58. Haque S, Rakieh C, Parker B, Jackson M, Day P, Alexander YM, Bruce IN. Endothelial cell abnormalities in SLE. Lupus 2010, 19(1 suppl):1-185.
59. Hall JC, Rosen A. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol 2010, 6:40-49. 10.1038/nrrheum.2009.237, 20046205.
60. Lindner DJ. Interferons as antiangiogenic agents. Curr Oncol Rep 2002, 4:510-514. 10.1007/s11912-002-0065-4, 12354364.
61. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006, 25:383-392. 10.1016/j.immuni.2006.08.010, 16979570.
62. Thacker SG, Duquaine D, Park J, Kaplan MJ. Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells. Lupus 2010, 19:288-299. 10.1177/0961203309353773, 3151666, 20068018.
63. Lian ZX, Kikuchi K, Yang GX, Ansari AA, Ikehara S, Gershwin ME. Expansion of bone marrow IFN-alpha-producing dendritic cells in New Zealand Black (NZB) mice: high level expression of TLR9 and secretion of IFN-alpha in NZB bone marrow. J Immunol 2004, 173:5283-5289.